Paul J. Orchard
Elite in Leukodystrophy
Check Dr. Paul J. Orchard's experience treating your condition:
About Dr. Paul J. Orchard

Paul Orchard is a Pediatric Hematologist Oncologist and a Pediatrics specialist in Minneapolis, Minnesota. He has been an author on 166 peer reviewed articles and participated in 18 clinical trials in the past 15 years. He is licensed to treat patients in MN.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 22 clinical trials in the past 15 years. In particular, he has co-authored 38 articles and participated in 10 clinical trials in the study of Leukodystrophy.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Paul J. Orchard it is best to call his office and ask if your insurance is accepted.

Call to see if your plan is accepted.
720 Washington Ave SE, #200, Minneapolis, MN
Other Locations
2450 Riverside Ave, Minneapolis, MN
Background & Education
Graduate Institution
Warren Alpert Medical School Of Brown University, 1984
University of Wisconsin Hospital
Pediatric Hematology Oncology
Pediatric Hematology-Oncology in MN
Board Certifications
University of Minnesota, Minneapolis
Hospital Affiliations
M Health Fairview University Of Minnesota Medical Center - West Bank Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

22 Clinical Trials

MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG
Sleeping Beauty Transposon-Engineered Plasmablasts for Expression and Delivery of Alpha-L-iduronidase in Patients With Hurler Syndrome That Have Previously Undergone Allogeneic Transplantation
A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤17 Years of Age With Cerebral Adrenoleukodystrophy (CALD)
Pilot Study of Administration of Intravenous Laronidase Following Allogeneic Transplantation for Hurler Syndrome
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Osteopetrosis
Treatment of High Risk, Inherited Lysosomal And Peroxisomal Disorders by Reduced Intensity Hematopoietic Stem Cell Transplantation
Intrathecal Enzyme Replacement Therapy For Patients With Mucopolysaccharidosis Type I (Hurler Syndrome)
Early Diagnosis Of Childhood Cerebral Adrenoleukodystrophy
Allogeneic Hematopoietic Stem Cell Transplantation for Standard Risk Inherited Metabolic Disorders
Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders
Reduced Intensity Allogeneic Transplantation For Severe Osteopetrosis Incorporating A Second Cd34 Selected Graft
Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation
Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation
MT2014-14 Intrathecal Administration of Mesenchymal Stem Cells (IT-MSC) for the Treatment of Advanced Cerebral Adrenoleukodystrophy (cALD)
View 20 Less Clinical Trials -

174 Total Publications

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors